Charles Brynelsen is President & VP at ABBOTT LABORATORIES (ABT). They have made 5 open-market trades across 2 companies since 2019, most recently 2026-02-12.
CIK 0001712459
2 open-market purchases totalling $482K since 2025, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| COCH | 1,050,000 | $7.4M |
| ABT | 43,550 | $5.0M |
| Total | $12.4M |
Shares reported on the most recent Form 4, priced at the 2026-02-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| COCH | BUY | 2026-02-12 | 2026-02-17 | $0.40 | $400K | +0.6% | +16.1% | -2.8% |
| COCH | BUY | 2025-05-22 | 2025-05-27 | $1.65 | $82K | -10.3% | -12.9% | -34.1% |
| ABT | SELL | 2021-03-01 | 2021-03-02 | $120.61 | $242K | -4.1% | -2.3% | -13.1% |
| ABT | SELL | 2020-03-02 | 2020-03-03 | $77.89 | $277K | +1.2% | -1.5% | +15.3% |
| ABT | SELL | 2019-03-01 | 2019-03-04 | $78.00 | $78K | +0.5% | +1.2% | -3.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.